← Eichor
Condition: Intraperitoneal Chemotherapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intraperitoneal Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Su
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351475A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperth
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06685887Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05913674Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
Phase 2 · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04282356PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Phase 2 · 1 location(s) · Banner Health · NCT07178808Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Phase 2 · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06800391Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
Phase 3 · 1 location(s) · University of Southampton · NCT06513065Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With
NA · 2 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07493876Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Phase 2 · 1 location(s) · Michael Bau Mortensen · NCT03280511Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
Phase N/A · 2 location(s) · Technische Universität Dresden · NCT05652348INTERACT Stomach-II
Phase 2 · 3 location(s) · Erasmus Medical Center · NCT07133490Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06475261Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Phase N/A · 1 location(s) · Oslo University Hospital · NCT02073500The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cy
Phase 1/Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT07460180Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07070973Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-
NA · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT04595929Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · 55 location(s) · ECOG-ACRIN Cancer Research Group · NCT07001748The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies
Phase 2 · 1 location(s) · The University of Hong Kong · NCT06367270HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Phase 2 · 1 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03275194Efficacy of Hyperthermic Intraperitoneal Chemotherapy
Phase 3 · 5 location(s) · Uppsala University · NCT04861558Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05415709PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
Phase 3 · 1 location(s) · Azienda Ospedaliera Universitaria Integrata Verona · NCT05303714A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologo
Phase 2 · 10 location(s) · Oncoinvent Solutions AS · NCT06504147Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Can
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05123807Preventive Use of PIPAC in Locally Advanced Gastric Cancer.
NA · 1 location(s) · National Research Oncology and Transplantology Center, Kazak · NCT06784765An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT02754115Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Phase 2 · 1 location(s) · Mayo Clinic · NCT04858009Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT07030283
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.